[HTML][HTML] Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis

F Migliorini, N Maffulli, J Eschweiler, A Baroncini… - Journal of Orthopaedic …, 2023 - Springer
Introduction The optimal dose of duloxetine in the management of fibromyalgia remains still
controversial. Therefore, a systematic review and meta-analysis to investigate efficacy and …

Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis

YN Lian, Y Wang, Y Zhang, CX Yang - International Journal of …, 2020 - Taylor & Francis
Objectives: The objective of this systematic review was to assess the analgesic efficacy of
duloxetine (DLX) for fibromyalgia (FM) and find out which dosage between 60 mg/d DLX …

[HTML][HTML] Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

EHS Choy, PJ Mease, DK Kajdasz, MM Wohlreich… - Clinical …, 2009 - Springer
The purpose of this report is to describe the overall safety profile of both short-and longer-
term duloxetine treatment of fibromyalgia. Data from four double-blind, randomized, placebo …

[HTML][HTML] Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews

ÁD Farias, L Eberle, TA Amador… - Advances in …, 2020 - SciELO Brasil
Background: Duloxetine and amitriptyline are antidepressants used in the treatment of
fibromyalgia. In published systematic reviews, there is no agreement about which drug is …

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia

AS Chappell, LA Bradley, C Wiltse… - … journal of general …, 2009 - Taylor & Francis
Objective: Assess the efficacy of duloxetine 60/120 mg (N= 162) once daily compared with
placebo (N= 168) in the treatment of patients with fibromyalgia, during six months of …

Duloxetine for the management of fibromyalgia syndrome

BA Scholz, CL Hammonds… - Journal of pain …, 2009 - Taylor & Francis
Fibromyalgia syndrome (FMS) is a widespread pain condition associated with a wide range
of additional symptoms including fatigue, insomnia, depression, anxiety and stiffness …

Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia

PJ Mease, IJ Russell, DK Kajdasz, CG Wiltse… - Seminars in arthritis and …, 2010 - Elsevier
OBJECTIVES: To assess the long-term safety, tolerability, and efficacy of duloxetine in
patients with fibromyalgia. METHODS: We report results from the 6-month extension phases …

Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial

LM Arnold, D Clauw, F Wang, J Ahl, PJ Gaynor… - The Journal of …, 2010 - jrheum.org
Objective. To investigate the efficacy of flexible dose duloxetine 60–120 mg/day on changes
in fibromyalgia (FM) symptoms assessed by the Patient Global Impression of Improvement …

[HTML][HTML] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients

M Murakami, K Osada, H Mizuno, T Ochiai… - Arthritis research & …, 2015 - Springer
Introduction Fibromyalgia is characterized by widespread pain and is often accompanied by
accessory symptoms. There are limited treatment options for this condition in Japan …

Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial

A Bidari, E Moazen-Zadeh, B Ghavidel-Parsa… - DARU Journal of …, 2019 - Springer
Background Duloxetine and pregabalin are among the most widely used medications in the
treatment of patients with fibromyalgia syndrome (FM). Objectives To add to the very few …